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Abstract In a search for genes induced by DNA-damaging
agents, we identified two genes that are activated by methyl
methanesulfonate (MMS). Expression of both genes is regulated
after endoplasmic reticulum (ER) stress via the unfolded protein
response (UPR) pathway. The first gene of those identified is the
molecular chaperone BiP/GRP78. The second gene, Mif1, is
identical to the anonymous cDNA KIAA0025. Treatment with
the glycosylation inhibitor tunicamycin both enhances the
synthesis of Mif1 mRNA and protein. The Mif1 5P flanking
region contains a functional ER stress-responsive element which
is sufficient for induction by tunicamycin. MMS, on the other
hand, activates Mif1 via an UPR-independent pathway. The gene
encodes a 52 kDa protein with homology to the human DNA
repair protein HHR23A and contains an ubiquitin-like domain.
Overexpressed Mif1 protein is localized in the ER.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Treatment of mammalian cells with genotoxic agents elicits
a complex response, involving the induction of a variety of
genes. Several signal transduction pathways can be activated,
depending on the kind of genotoxic agent used. These include
the UV response [1], the ATM/p53-dependent [2] and the un-
folded protein response (UPR) pathways [3,4]. Proteins in-
duced by genotoxic agents are involved in various cellular
processes, such as inter- and intra-cellular signaling, cell cycle
regulation and apoptosis. The spectrum of genes induced by
genotoxic agents overlaps partially with those activated by
other stimuli, like growth factors, serum starvation or non-
genotoxic cellular stress [5]. In the course of a search for genes
that are induced by DNA-damaging agents, we have applied
the method of di¡erential display to identify genes that are
induced by the methylating agent methyl methanesulfonate
(MMS), a strong mutagen and carcinogen. MMS reacts
with the N7 atom of guanine and the N3 atom of adenine
in DNA. In addition, it also reacts with -SH groups in pro-
teins [6]. Here we will describe the identi¢cation of a novel
endoplasmic reticulum (ER) stress-inducible gene, called Mif1
by us. Enhanced Mif1 mRNA levels were found after treat-
ment with MMS, but also after osmotic shock and exposure
to the ER stress inducer tunicamycin. The Mif1 gene encodes
a 52 kDa protein which contains a ubiquitin-like domain and
shows resemblance to the human DNA excision repair protein
HHR23A.
Proteins destined for secretion, for tra⁄cking to the lyso-
somes or for integration into the membranes are translocated
across the ER membrane as unfolded polypeptide chains dur-
ing translation. The molecular chaperones BiP, which binds to
misfolded proteins, and GRP94 are involved in the proper
folding of these nascent proteins. Exposure of cells to ER
stress leads to an enhanced level of unfolded proteins and a
reduced level of free BiP. This decrease in free BiP protein has
been suggested to be the trigger for the activation of UPR, a
pathway that is conserved from yeast to mammalian cells [3].
A novel ER stress response element (ERSE) was recently
identi¢ed, which is present in multiple copies in the promoters
of most known mammalian ER stress-inducible genes [7,8].
These ERSEs are necessary and su⁄cient for induction of
BiP after treatment with tunicamycin [7,8]. NF-Y and YY1,
two ubiquitously expressed transcription factors, were shown
to bind to the CCAAT and the CCACG parts of the ERSE,
respectively [9,10]. Regulated expression of the ERSE-contain-
ing genes is probably achieved via a still unknown protein. An
ER stress-inducible complex (ERSF) has been found in HeLa
cells, which binds to the ERSE. Binding of ERSF to ERSE
requires a conserved GGC motif within the 9 bp GC-rich
region that separates the NF-Y and YY1 binding sites [8].
The identity for ERSF has not yet been established, but the
basic leucine-zipper protein ATF6 has been suggested as a
component of the ERSF complex [7].
Activation of the UPR leads to enhanced expression of two
classes of gene products. One group consists of ER-resident
proteins, involved in protein folding, such as the ER chaper-
ones BiP and GRP94 or protein disul¢de isomerase. The other
class contains non-ER-resident proteins such as the growth
arrest and DNA damage-inducible GADD45 and GADD153
[11,12]. We show that Mif1 most likely belongs to the former
group.
2. Materials and methods
2.1. Cell culture and treatments
The following cells are used in this study: normal human diploid
skin ¢broblast strains VH10 (kindly provided by Dr. J.W.I.M. Si-
mons, Leiden University Medical Center) and 1BR2 [13], SV40-trans-
formed normal human skin ¢broblasts MRC-5 [13] and VH10SV [14],
MMS-sensitive AT4BI skin ¢broblasts derived from an ataxia telan-
giectasia (AT) patient [13], SV40-transformed AT ¢broblast strain
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AT5BIVASV [13] and the cervix carcinoma cell line HeLa. Cells were
cultured on Dulbecco’s MEM (DMEM) (Gibco-BRL, Life Technol-
ogies, Paisley, UK), supplemented with 8% fetal calf serum (FCS,
Gibco-BRL). Before treatment, all cells (except HeLa) were grown
to con£uence and serum-starved for 3 days in DMEM supplemented
with 0.5% FCS. Prior to UV-A, B or C irradiation, the medium was
removed and stored, and the cells were washed twice with phosphate-
bu¡ered saline (PBS). Irradiation with UV-A occurred in PBS at a
dose rate of 9.8 kJ/m2/min. The dose rate for UV-B and UV-C irra-
diation was 10 and 0.5 J/m2/s, respectively. After UV irradiation, the
stored culture medium was added back to the dishes. X-radiation was
performed with an Andrex Smart 225 source at a dose rate of 1 Gy/
min. Heat shock was performed by incubating the cells in a 42‡C
water bath for 5 min followed by further incubation in a 37‡C incu-
bator. Osmotic stress was applied by adding sodium chloride to the
cells up to an added concentration of 0.3 M for 5 min. Then the cells
were washed with PBS and further incubated with conditioned me-
dium. All other treatments were performed by incubating the cells as
indicated. Tunicamycin was purchased from Sigma Chemical Com-
pany. (St. Louis, MO, USA) and MMS from Merck (Darmstadt,
Germany).
2.2. Reverse transcription, di¡erential display and fragment isolation
Di¡erential display was performed in triplicate essentially as de-
scribed [15] with a few modi¢cations. In short, cytoplasmic RNA
was treated with RNase-free DNase. M-MLV (Gibco-BRL) reverse
transcriptase was used for the reverse transcription reaction in the
presence of one base-anchored oligo-dT downstream primers extended
with 4 nucleotides to create a HindIII site at the 5P end of the primers
[16]. Ampli¢cation reactions were performed in the presence of the
same downstream primer, an arbitrary random decamer primer and
[33P]K-dATP as the labeling nucleotide under the following PCR pro-
tocol: 30 s 94‡C, 60 s 40‡C and 30 s 72‡C for 40 cycles. The following
primer combinations were used to identify the MMS-inducible frag-
ments (Mif) described in Section 3: Mif1: downstream primer 5P-
AAGCT11C and upstream primer 5P-AAGCTTGATTGCC. Mif2:
downstream primer 5P-AAGCT11A and upstream primer 5P-
CTGCTTGATG. PCR products were concentrated in a vacuum cen-
trifuge and separated on 6% denaturing polyacrylamide gels. Gels
were dried and, after autoradiography, bands of interest were excised
from the gel. DNA was recovered from the gel by overnight elution at
37‡C in elution bu¡er (0.5 M ammonium acetate, 10 mM magnesium
acetate, 1 mM EDTA (pH 8.0) and 0.1% SDS) as in [17]. Isolated
DNA fragments were re-ampli¢ed (30 s 94‡C, 60 s 42‡C and 30 s 72‡C
for 30 cycles) with the same upstream and downstream primer combi-
nation and then cloned into the pCR2.1 TA-cloning vector (Invitro-
gen Corporation, Leek, The Netherlands).
2.3. DNA sequencing and database analysis
Double-stranded DNA from the cloned di¡erential display frag-
ments was sequenced with M13 forward and reverse primers and a
T7 sequencing kit (Pharmacia Biotech, Uppsala, Sweden). The iso-
lated di¡erential display fragments were identi¢ed with the Wisconsin
Package Version 9.1 (Genetics Computer Group (GCG), Madison,
WI, USA).
2.4. RNA isolation and Northern blotting
RNA isolation and Northern blotting were performed as described
previously [18]. To test for expression of Mifs, the isolated di¡erential
display fragments were labeled by random priming with [32P]K-dATP.
A 1000 bp KIAA0025 5P fragment was ampli¢ed from a cDNA de-
rived from MMS-treated human skin ¢broblasts with the use of the
following primer combination: sense 5P-CGTGAACGGTCGTTG-
CAGA and antisense 5P-GCAGGTACATAACAACGGT. A 667 bp
fragment for p21WAFÿ1 was generated from the same cDNA prepara-
tion with the following primers: sense 5P-CCCCAGCCTCTGGCAT-
TA and antisense 5P-GTGTCCCTTCCCCTTCCA. A 348 bp frag-
ment of the GRP94 cDNA was ampli¢ed by PCR with the primers
sense: 5P-TCATCACAGACGACTTCC and antisense: 5P-CCTTCA-
TTCTTTCCACATAC. A 420 bp PstI fragment from pHS208 [19]
was used for detection of Hsp27 mRNA expression. cJun expression
was tested with a 1 kb HindIII-PstI fragment from pRSV-cJun [20]. A
600 bp PstI/XhoI insert containing the GADD153 cDNA was isolated
from pBSIISK (kindly provided by Dr. R. Bernards). A rat glycer-
aldehyde-3-phosphate-dehydrogenase (GAPDH) probe derived from
the 1.3 kb PstI fragment from pRGAPDH [21] and a 1500 bp PstI
fragment of human elongation factor 1 [22] were used as loading
controls.
2.5. Construction of a myc epitope-tagged Mif1 expression vector
The Mif1 cDNA was ampli¢ed from pBluescriptKIAA0025 (kindly
provided by Dr. T. Nagase) by means of the proofreading Pfu DNA
polymerase (Stratagene Cloning Systems, La Jolla, CA, USA) and the
following primer combination: sense 5P-CGGAATTCCGGCCGC-
CATGGAGTCCGAGACC and antisense 5P-CGCGGATCCGCG-
GTTTGCGATGGCTGGGGGGCC. The PCR fragment was cloned
into the EcoRI/XhoI sites of pCDNA3.1A (Invitrogen Corporation,
Leek, The Netherlands). The DNA sequence for the resulting myc
epitope-tagged Mif1 cDNA was con¢rmed by sequencing.
2.6. Antibodies and immunoprecipitation
Polyclonal antibodies against Mif1 were raised by immunizing rab-
bits with the Mif1 peptide H2N-EPAGSNRGQYPEDSS-CONH2
(Eurogentec Bel. S.A., Herstal, Belgium). The speci¢city of the anti-
bodies was tested by Western blotting on lysates derived from cells
transiently transfected with the myc epitope-tagged Mif1 expression
vector. Induction of endogenous Mif1 protein was determined by
immunoprecipitation as described before [18].
2.7. Immuno£uorescence
Cells transfected with a myc epitope-tagged Mif1 expression vector
were ¢xed with acetone 48 h post-transfection. Immuno£uorescence
was performed as described before [23]. Mif1 protein was detected by
double labeling, with mouse monoclonal anti-myc antibody 9E10 [24]
and rabbit polyclonal anti-Mif1 peptide antibody 421, followed by
incubation with a rhodamine-conjugated anti-mouse IgG and a
FITC-conjugated anti-rabbit IgG (Jackson Immunoresearch Labora-
tories, West Grove, PA, USA). Nuclear DNA was stained with 2,4-
diamidino-2-phenylindole (DAPI).
2.8. Cloning of Mif1 promoter sequences
Screening a £ow-sorted chromosome 16 cosmid library from the
Los Alamos National Laboratory [25] with a full-length 1860 bp
cDNA probe for Mif1 resulted in 13 positive clones. In a re-screen
performed by Southern blotting, two of these clones hybridized to
both a 5P and a 3P probe derived from the Mif1 cDNA and contained
a fragment of approximately 10 kb of the Mif1 gene. FISH analysis
assigned both clones to chromosome 16q21. The DNA for the two
clones was digested with EcoRI, ligated into pIC20H [26] and sub-
clones containing a 4.2 kb insert hybridizing to a 5P 250 bp probe for
Mif1 were isolated. Sequence analysis was performed for two sub-
clones.
2.9. Construction of luciferase reporter plasmids
To obtain a luciferase reporter construct that is regulated by Mif1
promoter sequences, a MluI/NcoI fragment from the pIC20H-Mig1
plasmid, corresponding to nucleotides 3765 up to +96 (relative to the
KIAA0025 cDNA sequence), was cloned into pGL3basic (Promega
Corporation, Madison, WI, USA). The nucleotide sequence of this
promoter fragment can be retrieved from the EBI database (accession
number AJ250249).
Deletion mutants were generated by digesting the Mif13765!96-
pGL3basic construct with KpnI in combination with either BamHI,
PstI or PvuII, followed by re-ligation according to standard cloning
protocols. The control vectors pGL3TATA and 5xJun2TRE were
kindly provided by Dr. H. van Dam, Leiden University Medical Cen-
ter.
To obtain luciferase reporter constructs containing only the wild-
type or mutated Mif1-C1 (nucleotides 398 to 375) or the ¢rst ERSE
(nucleotides 365 to 343) of BiP, double-stranded oligonucleotides
with the appropriate sequences (Fig. 4B) were ligated into the KpnI
and BglII sites of the pGL3 promoter vector (Promega Corporation,
Madison, WI, USA), which contains the SV40 minimal promoter up-
stream of the luciferase coding sequence. DNA sequences of the in-
serted region were con¢rmed by sequencing.
2.10. Luciferase assays
Exponentially growing HeLa cells, cultured on 50 mm Petri dishes,
were transiently transfected with the DEAE dextran method [27] with
2 Wg plasmid DNA that had been puri¢ed by two rounds of CsCl
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centrifugation. After 24 h, triplicate dishes were either mock-treated
or treated as indicated and further cultured for 8 h at 37‡C. Then, the
cells were lysed in 200 Wl lysis bu¡er (5 mM Tris/phosphate pH 7.8,
400 WM DTT, 400 WM trans-1,2-diaminocyclohexane-N,N,NP,NP-tet-
raacetic acid (Sigma Chemical Company, St. Louis, MO, USA), 10%
glycerol and 1% Triton X-100) at room temperature for 20 min fol-
lowed by centrifugation. Luciferase activity was measured with Lucif-
erase Assay Substrate (Promega Corporation, Madison, WI, USA) on
a Lumat LB9501 luminometer.
3. Results
3.1. Identi¢cation of two MMS-inducible cDNA fragments
In order to identify genes that are induced by DNA-dam-
aging agents, human diploid skin ¢broblasts were mock-
treated or exposed to either UV-C, MMS or ionizing radia-
tion. RNA was isolated 4 h after treatment and di¡erential
display was performed as described in Section 2. To con¢rm
that di¡erentially displayed fragments indeed represented dif-
ferentially expressed genes, they were isolated from the poly-
acrylamide gel, re-ampli¢ed and used as a probe on a North-
ern blot (Fig. 1A). The nature of the corresponding genes was
determined as described in Section 2. Here, we describe the
identi¢cation of two MMS-inducible fragments (Mifs). Mif1
was 97% identical to an anonymous cDNA, that previously
has been described as KIAA0025 (GenBank accession number
D14695). Mif2 represents BiP/GRP78 (95% identity, Gen-
Bank accession number X87949).
3.2. Induction of Mifs by DNA-damaging agents
Fig. 1A shows the mRNA induction of Mif1 and Mif2 in
MMS-treated human diploid skin ¢broblasts. Induction oc-
curred with similar kinetics for all non-transformed and trans-
formed cells tested (Fig. 1B and data not shown), indicating
that the induction is a general phenomenon. No induction was
found for either Mif gene after exposure to UV-C or ionizing
radiation, under conditions where the DNA damage-inducible
gene p21WAFÿ1 was indeed induced. There are several explan-
ations for this observation: e.g. the induction of Mif genes
Fig. 1. A: Mif1 and Mif2 are MMS-inducible genes. Induction of Mif1 and Mif2 was tested by Northern blotting in VH10 human diploid skin
¢broblasts. mRNA was isolated at di¡erent time points after treatment with UV-C (15 J/m2), MMS (1 mM) or X-ray (5 Gy). Induction of
p21WAFÿ1 is shown as a positive control for gene induction by the di¡erent treatments. Expression of GAPDH is shown as a loading control.
B: Mif1, Mif2 and GRP94 are induced by MMS in diploid ¢broblasts and SV40-transformed cells. Human diploid (1BR2, AT4BI) and SV40-
transformed (MRC-5, VH10SV, AT5BISV) ¢broblasts were continuously treated with MMS (1 mM) for 1, 2 or 4 h. Induction of Mif1, Mif2
and GRP94 was tested by Northern blotting. Expression of GAPDH is shown as an internal control. Note that SV40-transformed cells express
higher basal levels of the GAPDH gene than diploid ¢broblasts.
Fig. 2. A: Induction of Mif1 and Mif2 is not a general phenomenon of DNA-damaging agents. Induction of Mif1 and Mif2 by di¡erent
DNA-damaging agents was assayed by Northern blotting. VH10 cells were treated with the alkylating agents MMS (1 mM) or EMS (20 mM),
the crosslinking agent mitomycin C (MMC, 6 Wg/ml), or the X-ray-mimicking agent bleomycin (Blm, 40 Wg/ml). RNA was isolated after the in-
dicated incubation periods. Lanes marked with time point zero indicate mock-treated cells. A probe for p21WAFÿ1 was used as a positive con-
trol for gene induction and a probe for GAPDH was used as a loading control. B: Induction of Mif1 and Mif2 by UV is wavelength-depen-
dent. VH10 diploid ¢broblasts were irradiated with either UV-A (150 kJ/m2), UV-B (200 J/m2) or UV-C (15 J/m2). After irradiation, cells were
cultured at 37‡C as indicated and expression of Mif1 and Mif2 was tested by Northern blotting. Lanes marked with time point zero indicate
mock-treated controls. A probe for the early response gene cJun was used as positive control.
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after exposure to UV-C and X-ray has di¡erent kinetics, or
the induction is speci¢c for alkylating agents. To discriminate
between these possibilities, human diploid skin ¢broblasts
were treated with di¡erent DNA-damaging agents and Mif
expression was tested by Northern blotting. The results shown
in Fig. 2A suggest that the induction of the two Mif genes is
not a general response to genotoxic agents. Mif1 was induced
by MMS and to a lesser extent by EMS. BiP, the gene that
corresponds to Mif2, was induced solely after treatment with
MMS. Treatment with the crosslinking agent mitomycin C or
the X-ray-mimicking agent bleomycin did not result in acti-
vation of Mif genes. Induction of the DNA damage-inducible
gene p21WAFÿ1 is shown as a control.
To obtain more insight into the spectrum of treatments that
induce the Mif genes, human diploid skin ¢broblasts were
irradiated with UV light of di¡erent wavelengths (UV-C:
100^290 nm, UV-B: 290^320 nm, UV-A: 320^400 nm), fol-
lowed by RNA isolation at early time points (Fig. 2B). As
shown, only UV-A irradiation resulted in an enhanced expres-
sion of both Mif genes. Furthermore, Mif2 was slightly induc-
ible by UV-B but not by UV-C. Mif1 was not induced by UV-
B, whereas UV-C resulted even in a decrease of the basal Mif1
mRNA level. Induction of the early response gene cJun is
shown as a control.
Irradiation of cells with UV of increasing wavelengths leads
to a relative increase in the production of reactive oxygen
species, resulting in more damage to protein and membranes
than to DNA. Likewise, MMS is supposedly an agent that, in
comparison to EMS, produces more damage to proteins,
membranes and organelles than to DNA [6]. In addition,
apurinic sites, the lesions that remain after repair of methyl-
ated bases, are indeed not su⁄cient for the induction of BiP
[12]. Our results suggest that Mif1 activation also requires a
DNA damage-independent signal.
3.3. Mif1 is a stress-inducible gene
To test the hypothesis that Mif1 is induced by signals in-
dependent of DNA damage, HeLa cells were exposed to var-
ious kinds of stress. Addition of hydrogen peroxide resulted
only in a slight increase in Mif1 mRNA in HeLa cells (Fig.
3A), and this induction was not found in H2O2-treated human
diploid ¢broblasts (data not shown). Heat shock treatment
had no e¡ect on Mif1 expression (Fig. 3A), while this treat-
ment clearly induced heat shock protein hsp27 mRNA. In
contrast, osmotic shock was found to be a strong inducer of
Mif1 (Fig. 3A).
Furthermore, we show that not only BiP (Mif2) is induced
by MMS ([12] and Fig. 1A,B) but also GRP94, another UPR-
responsive ER-resident molecular chaperone (Fig. 1B). Simi-
larly, some of the genes that were originally identi¢ed as DNA
damage-inducible genes, such as GADD45 and GADD153,
are also activated by ER stress ([11,12] and Fig. 3B). We
subsequently tested whether Mif1 represents a novel member
of the family of ER stress-responsive genes. Indeed we found
Fig. 3. A: Mif1 and Mif2 genes are activated by osmotic stress. Exponentially growing HeLa cells were treated with either MMS (1 mM) or
hydrogen peroxide (0.5 mM) for the indicated incubation time. Heat shock was performed by incubating HeLa cells at 42‡C for 5 min, fol-
lowed by a further incubation at 37‡C. Osmotic stress was given by adding NaCl to the medium up to an extra concentration of 0.3 M NaCl.
After 5 min, the medium was removed and replaced by conditioned medium. The zero time points indicate mock-treated controls. Mif1 and
Mif2 expression was tested by Northern blotting using a probe for the ¢rst 1000 bp of the KIAA0025 cDNA. Induction of Hsp27 is shown as
a control for heat shock treatment. B: Mif1 is induced by tunicamycin. SV40-transformed VH10 cells were incubated with tunicamycin (10
WM) for the indicated period and induction of Mif1, Mif2, GADD153 and GRP94 was tested by Northern blotting. A probe for the human
elongation factor 1K is used as a loading control.
C
Fig. 4. A: The Mif13765!96 promoter fragment is activated by tunicamycin and MMS. HeLa cells were transfected with a luciferase reporter
construct under control of the Mif13765!96 promoter fragment as described in Section 2. A 5xJun2TRE-luciferase construct was transfected
as a positive control for UV irradiation and a pGL3TATA was included as a negative control. After 16 h, cells were either mock-treated or
treated in triplicate with tunicamycin (10 WM), MMS (1 mM), osmotic shock (as described in Section 2) or irradiated with UV-C (15 J/m2) and
further incubated at 37‡C for 8 h. Finally, the cells were lysed and luciferase activity was measured as indicated in Section 2. B: MMS and tu-
nicamycin di¡erentially regulate the Mif1 gene. Luciferase reporter constructs under the control of promoter fragments as indicated (see Section
2) were transfected into exponentially growing HeLa cells. Triplicate dishes were mock-treated or exposed to MMS (1 mM) or tunicamycin
(10 WM) 16 h after transfection for a period of 8 h. Then the cells were lysed and luciferase activity was measured as described in Section 2.
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that Mif1 is strongly activated by the glycosylation inhibitor
and ER stress inducer tunicamycin, with kinetics comparable
to those of BiP, GRP94 and GADD153 (Fig. 3B).
3.4. 5P Upstream sequence of the Mif1 gene contains an ERSE
element that is su⁄cient for activation by tunicamycin
The Mif1/KIAA0025 gene has been mapped to chromosome
16 [28]. To isolate a promoter fragment of the gene, we
screened a chromosome 16 cosmid library. Two identical 4.2
kb subclones were isolated that contained a 3 kb fragment
upstream of the Mif1 coding sequences, exon 1 (248 bp)
and part of the ¢rst intron. An 861 bp MluI/NcoI fragment,
corresponding to nucleotides 3765 up to +96 of the Mif1
gene, was cloned into the pGL3basic luciferase reporter vec-
tor. To test the inducibility of this construct, HeLa cells were
transfected with this vector or with the control vector
pGL3TATA or a 5xJun2TRE-luciferase vector, and were
treated with either UV-C, MMS, osmotic stress or tunicamy-
cin. Activation of the transcription activity of the reporter
constructs was measured as described in Section 2. In agree-
ment with the results obtained by Northern blotting, we did
not observe a signi¢cant e¡ect of UV-C on the Mif1 promoter
activity, while the 5xJun2TRE, included as a positive control,
was clearly induced by UV-C (Fig. 4A). Osmotic shock had
no e¡ect on luciferase activity in Mif13765!96-pGL3basic-
transfected cells (Fig. 4A), suggesting that the element re-
quired for induction of Mif1 by osmotic stress is located out-
side this promoter region. In contrast, MMS or tunicamycin
treatment resulted in an enhanced luciferase activity (Fig. 4A),
although tunicamycin appears to be a stronger enhancer of
the Mif13765!96 promoter activity than MMS.
Induction of BiP by tunicamycin requires multiple ERSE
sequences in the promoter of the BiP gene. The Mif13765!96
region contains three ERSE-like sequences (Table 1). We
called these ERSE-like sequences C1^C3. Reporter plasmids
containing the luciferase gene controlled by the BiP ERSE1,
the Mif1-C1 or a mutated mif1-C1 (Fig. 4B) were transfected
into HeLa cells, followed by treatment with MMS or tunica-
mycin. The Mif1-C1 is as active in response to tunicamycin as
the BiP ERSE1 (Fig. 4B). In contrast to results described for
the BiP ERSE1, mutation of the second cytosine in the
CCAAT-box of the Mif1-C1 to adenine had only little e¡ect
on induction of luciferase activity by tunicamycin (Fig. 4B).
Furthermore, MMS could not activate ERSE1 of BiP or
Mif1-C1, whereas the cells transfected with Mif13765!96-
pGL3basic showed a clear induction after MMS treatment.
This shows that the ¢rst ERSE of BiP or Mif1 is not su⁄cient
for induction by MMS and suggests that activation of Mif1
by MMS does not involve the UPR.
3.5. Identi¢cation of an 122 bp promoter region that facilitates
induction of Mif1 by MMS via an UPR-independent
mechanism
To dissect the signalling pathways used to activate Mif1 by
MMS or tunicamycin, deletion mutants were generated of the
Mif13765!96 promoter fragment (Fig. 4B). Luciferase activ-
ity of lysates derived from HeLa cells transfected with these
mutant promoter luciferase plasmids showed that the
PvuII3654!96 and the PstI3262!96 fragments possessed an
MMS-inducible promoter activity that is comparable to that
of Mif13765!96 (Fig. 4B). Deletion up to the BamHI site
(BamHI3140!96) resulted in a strong decrease of basal activ-
ity and loss of MMS inducibility, while the activation of lu-
ciferase by tunicamycin was not a¡ected (Fig. 4B). Thus, the
fragment of 122 bp (PstI-BamHI) that lacks an ERSE is re-
quired for the induction of luciferase activity by MMS.
3.6. Mif1 protein level is enhanced by tunicamycin
To test whether induction of Mif1 mRNA results in an
enhanced protein level, Mif1 protein was immunoprecipitated
from a [35S]methionine-labeled lysate derived from tunicamy-
cin or mock-treated VH10SV cells. In untreated cells, Mif1
was detectable as a faint band of approximately 52 kDa (Fig.
5). Treatment with tunicamycin resulted in a 5^10-fold rise of
the Mif1 protein level.
3.7. Overexpressed myc-tagged Mif1 is localized in the ER
We showed that the Mif1 gene is activated by tunicamycin,
a strong inducer of ER stress. In addition, we showed that the
C1 region of the promoter has properties of a functional
ERSE, indicating that Mif1 is a UPR-regulated gene. Two
classes of genes are controlled by UPR: those encoding ER-
resident proteins or nuclear proteins. Therefore, we wished to
determine the cellular localization of Mif1 protein. Since we
failed to detect endogenous Mif1 protein by immuno£uores-
cence, we transiently transfected HeLa cells with a myc-tagged
Mif1 expression vector. Localization was established by im-
muno£uorescence with both an anti-Mif1 polyclonal antibody
Fig. 5. A: Mif1 protein is induced upon treatment with tunicamy-
cin. SV40-transformed VH10 ¢broblasts were treated for 3 h with
10 WM tunicamycin followed by pulse labeling with [35S]methionine
for 2 h in the presence of tunicamycin. Mif1 protein was immuno-
precipitated with rabbit polyclonal KMif1 antibody 421. The pre-im-
mune serum of the corresponding rabbit was used as a negative
control. B^D: Overexpressed Mif1 protein is localized in the ER.
HeLa cells were transiently transfected with a myc-tagged Mif1 ex-
pression vector. 48 h after transfection, Mif1 protein was stained by
double labeling with the KMif1 rabbit polyclonal antibody 421 (B)
or the Kmyc mouse monoclonal antibody 9E10 (C) and visualized
with an FITC-conjugated anti-rabbit IgG or a rhodamine-conju-
gated anti-mouse IgG, respectively. DNA was stained with DAPI
(D).
Table 1
ERSE-like sequences in the 5P £anking region of the Mif1 gene
BiP ERSE1 [7,8] : CCAAT cggcggcct CCACG
Mif1-C3: 3661: CCAAT ttccctggg CCTCA strand: (3)
Mif1-C2: 3123: CCAAT cggcgtccg GATCC strand: (3)
Mif1-C1: 393: CCAAT gggcggcag CCACA
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and an anti-myc monoclonal antibody. Mif1 was found
around the nucleus (Fig. 5B,C), in a structure resembling
the ER, just like the ER-resident protein GRP94 [29].
4. Discussion
4.1. Identi¢cation of MMS-inducible genes by di¡erential
display
MMS and other alkylating agents are well-known carcino-
gens which induce cellular stress by causing damage to DNA
and proteins. When exposed to alkylating agents, cells re-
spond in several ways, e.g. by the activation of transcription
of stress-responsive genes. Among such genes are the DNA
repair gene O6-methylguanine-DNA methyl-transferase [30],
the early response genes c-fos and c-jun [31], and the late
response gene collagenase [5]. These genes have in common
that they are also induced by other classes of DNA-damaging
treatments, such as ionizing radiation. A separate group of
genes activated by alkylating agents also shows speci¢city to-
wards protein-damaging treatments. In this report, we de-
scribe the identi¢cation of two MMS-inducible genes that
probably belong to the latter group. One of the genes we
identi¢ed by di¡erential display is BiP/GRP78, which we
called Mif2. This gene is known to be induced by agents
that a¡ect the ER, including alkylating agents. In this report,
we show that also GRP94, another ER stress-inducible gene,
is activated by MMS. In addition to GRP94, we identi¢ed
Mif1 as a novel MMS-inducible gene. Induction of this gene
was detected after treatment with MMS, but not after expo-
sure to UV-C or ionizing radiation.
4.2. Mif1 is a stress-inducible gene whose product is similar to
the human DNA excision repair protein HHR23A
Database analysis revealed that Mif1 corresponds to
KIAA0025, an anonymous ORF that was originally identi¢ed
in the human immature myeloid cell line KG-1. Expression of
this gene was found in all tissues tested [28]. No function or
functional domains were reported for the putative protein.
In this paper, we report that activation of the Mif1 gene
may be involved in a stress response pathway. Induction of
Mif1 by MMS was found in all cell lines tested. In addition,
we showed that induction of Mif1 was not restricted to MMS.
Osmotic stress, UV-A irradiation and treatment with the gly-
cosylation inhibitor tunicamycin also led to the activation of
the Mif1 gene. Mif1 was not induced in diploid ¢broblasts by
either TNFK or H2O2, under conditions that we could detect
activation of the stress-inducible transcription factor cJun
(data not shown). This indicates that a recently identi¢ed
Fig. 6. Alignment of Mif1 and HHR23A protein sequences (A) or Mif1 and ubiquitin (B). Identical amino acids are presented in black boxes,
whereas similar residues are show in gray boxes.
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UPR-independent signal transduction pathway from the ER
to the nucleus mediated by NFUB [32] will not stimulate Mif1
expression.
A Pearson and Lipman search for protein similarity using
FastA revealed that the predicted protein, encoded by the
Mif1 gene, contains an N-terminal ubiquitin-like domain
(UbL) and is similar (25% identity and 51% similarity over
261 residues) to the human nucleotide excision repair (NER)
protein HHR23A (Fig. 6).
The function of the UbL remains unknown, although an
increasing number of proteins containing such a sequence
have been described. However, it has been shown that the
UbL is essential for the function of yeast RAD23. Yeast cells
became UV-sensitive upon deletion of the UbL from RAD23,
while replacement of the UbL with ubiquitin rendered the
cells UV-resistant [33]. Recently, it was shown that RAD23
protein interacts with the 26S proteasome via the N-terminal
UbL and was rapidly degraded via the proteasome pathway.
Consequently, RAD23 was stabilized in yeast strains bearing
mutations in the proteasome subunits [34]. However, protea-
somal proteolysis of RAD23 protein is not required for e⁄-
cient NER [35]. Rather, it appears that binding of RAD23 to
the 19S regulatory complex of the proteasome increases the
rate and/or e⁄ciency of NER. Further studies will have to
elucidate whether the UbL of Mif1 associates to similar pro-
teins.
4.3. Mif1 is activated by UPR-dependent and UPR-independent
mechanisms
We showed that the Mif1 gene is strongly activated upon
treatment with the alkylating agent MMS, the glycosylation
inhibitor tunicamycin or by osmotic shock.
Recently, two laboratories independently de¢ned a consen-
sus sequence in the promoter for most mammalian genes that
are activated via the UPR upon ER stress. This sequence
consists of a CCAAT-box, followed by a 9 bp GC-rich spacer
region and a less well conserved CCACG motif. These ERSE
sequences are found in multiple copies and in both orienta-
tions in the promoter of most mammalian ER stress-respon-
sive genes [7,8]. The Mif13765!96 region contains three
CCAAT motifs, followed by a 9 bp CG-rich region. The ¢rst
ERSE sequence, which ends with a CCACA motif, is found
close to the TATAA-box in the (+) strand of the Mif1 gene.
We showed that ¢rst ERSE indeed functions as a bona¢de
ERSE. In analogy to other UPR-responsive genes, two other
ERSE-like sequences are found in the non-coding strand of
the ¢rst 765 bp promoter region of Mif1. These results
strongly suggest that Mif1 belongs to the group of UPR-re-
sponsive genes. This assumption is further underscored by the
fact that overexpressed Mif1 was localized to the ER,
although we are aware of the fact that an overexpressed pro-
tein will not necessarily reside in the same compartment of the
cell as its endogenous counterpart, which is expressed at lower
levels.
Induction of Mif1 by MMS or tunicamycin reaches similar
levels when tested by Northern blotting. However, when
tested in a luciferase assay, tunicamycin is a much more po-
tent activator of Mif13765!96 than MMS. A simple explan-
ation could be that induction of Mif1 by MMS requires multi-
ple sites, of which at least one is present in the Mif13765!96
fragment, while other activating transcription factors bind
outside this region. However, a disruption of the secondary
structure in the DNA of the Mif13765!96 fragment could
also be a likely explanation.
Studies with deletion mutants of the Mif1 promoter sug-
gested that ERSE-like sequences may not be involved in the
activation of Mif13765!96 by MMS. A 122 bp fragment
lacking an ERSE was required for the enhanced activity after
MMS treatment. Deletion of this fragment resulted in a loss
of basal activity and inducibility by MMS. A TFSEARCH
[36] using this 122 bp fragment as query revealed the presence
of an E-box class B motif. The group of B-class regulatory
proteins includes the upstream stimulatory factor (USF). USF
is an ubiquitously expressed complex consisting of two poly-
peptides, USF1 and 2, that can bind to the E-box as either
homo- or heterodimers. USF is involved in both basal tran-
scription and induction of transcription upon treatment with
insulin. Further studies will have to elucidate whether USF is
indeed required for the activation of Mif1 by MMS.
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